Research Paper Volume 16, Issue 5 pp 4841—4861
HOXC9 characterizes a suppressive tumor immune microenvironment and integration with multiple immune biomarkers predicts response to PD-1 blockade plus chemotherapy in lung adenocarcinoma
Figure 4. Hoxc9 knockdown arrested cell cycle and promoted cell apoptosis. (A–D) Hoxc9 knockdown arrested cell cycle of CMT167 cells and LCC cells. (E–H) Hoxc9 knockdown promoted cell apoptosis of CMT167 cells and LCC cells. (*P<0.05, **P<0.01, ***P<0.001).